May 13, 2020 / 11:58 AM / in 14 days

BRIEF-Applied Genetic Technologies Posts Quarterly Loss Of $0.50/Shr

May 13 (Reuters) - Applied Genetic Technologies Corp :

* AGTC ANNOUNCES FINANCIAL RESULTS AND BUSINESS UPDATE FOR THE QUARTER ENDED MARCH 31, 2020

* COMPANY ON TRACK TO PROVIDE MULTIPLE DATA READOUTS FOR XLRP AND ACHM CLINICAL PROGRAMS IN 2H 2020

* COMPANY ON TRACK FOR END OF PHASE 2 MEETING IN Q2 2020

* SEES MINIMAL COVID-19 IMPACT TO DATE

* QTRLY LOSS PER SHARE $0.50

* Q3 EARNINGS PER SHARE VIEW $-0.55 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below